Endobronchial Ultrasound Guided Transbronchial Needle Aspiration (EBUS-TBNA) for Mediastinal Re-staging of Non-small Cell Lung Cancer(NSCLC)
Not Applicable
Withdrawn
- Conditions
- Non Small Cell Lung Cancer
- Registration Number
- NCT00859742
- Lead Sponsor
- National Cancer Center, Korea
- Brief Summary
The aim of this study is to determine the diagnostic values of EBUS-TBNA in the mediastinal re-staging after induction treatment in patients with non-small cell lung cancer.
Primary objective:
1. To determine the sensitivity, specificity, positive predictive value, negative predictive value and the accuracy of EBUS-TBNA in the detection of mediastinal metastasis in mediastinal re-staging after induction treatment.
Secondary objectives:
1. To compare the diagnostic values of EBUS-TBNA and integrated PET/CT in mediastinal re-staging
2. To evaluate the changes of ultrasonographic features of mediastinal lymph nodes after induction therapy
3. To determine procedure related complications
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- Histologically proven non-small cell lung cancer
- Patients who have initially histologically proven N2 disease (Stage IIIA)
- Patients who underwent induction treatment (chemotherapy or chemoradiation therapy) and are considred for surgery
- Written informed consent
Exclusion Criteria
- Contraindications for bronchoscopy
- Medically inoperable patients
- Patients who are found to have M1 disease, inoperable T4 disease or supraclavicular metastasis after induction treatment
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method The diagnostic values of EBUS-TBNA in the mediastinal re-staging after induction treatment in non-small cell lung cancer. 1.5 years
- Secondary Outcome Measures
Name Time Method The diagnostic values of integrated PET/CT in the mediastinal re-staging after induction treatment in non-small cell lung cancer 1.5 years The changes of ultrasonographic features of mediastinal lymph nodes after induction therapy 1.5 years
Trial Locations
- Locations (1)
NCCKorea
🇰🇷Goyang, Gyeonggi-do, Korea, Republic of
NCCKorea🇰🇷Goyang, Gyeonggi-do, Korea, Republic of